Last updated: April 26, 2026
What is JP7627353, and what does it cover?
JP7627353 is a Japan patent publication (publication number JP7627353) that protects a drug-related invention in Japan. The request requires a scope-by-scope and claim-by-claim breakdown, plus a structured Japan-focused patent landscape (families, active/expired status, major competitors, and potential FTO touchpoints). That level of specificity depends on the actual bibliographic record and full text of JP7627353 (claims, description, drawings, dependent-claim structure, priority and filing history, and status).
No bibliographic or full-text content for JP7627353 is included in the prompt, and the provided material is insufficient to produce an accurate claim chart, scope map, or landscape assertions tied to this specific patent number.
What are the independent and dependent claims (scope map)?
A complete scope map requires the verbatim claim set (at minimum: claim 1 plus all dependent claims), including:
- claimed active ingredient(s) and their forms (salt, hydrate, polymorph, stereochemistry)
- claimed formulation parameters (dose, excipients, particle size, solvation state)
- claimed method of treatment endpoints (indication, disease stage, patient group)
- claimed manufacturing/kit/combination structure
- claim dependencies that narrow scope (A depends on B; C depends on B and D)
Those inputs are not available in the prompt.
What is the claim construction in practice (what is actually infringed)?
Claim construction requires parsing claim language and mapping key limitations to potential practicing products or processes:
- “comprising” vs “consisting of” language
- functional limitations (e.g., “wherein X has activity of Y”)
- numerical ranges and preferred ranges
- structural Markush elements (if present)
- combination ratios and regimen timing (if present)
Those inputs are not available in the prompt.
How does JP7627353 sit in its patent family (priority and related filings)?
A Japan patent landscape for a drug requires family analysis:
- earliest priority date(s)
- parallel filings in other jurisdictions
- continuation/divisional equivalents (if any)
- whether the Japanese claims align with counterpart jurisdictions
Those data are not available in the prompt.
What is the Japan landscape: grants, oppositions, and competing filings?
A Japan-focused landscape typically requires:
- whether JP7627353 is granted, pending, or lapsed
- any JPO office actions or amendments (as reflected in legal status)
- whether an invalidation trial has been filed
- the nearest prior art families (process and composition of matter)
- competing active ingredients and formulation patents in Japan
- any regulatory-driven exclusivities that affect FTO timing (if relevant)
None of these status and competitor identifiers can be derived from the prompt.
Key Takeaways
- A scope and claims analysis for JP7627353 requires the patent’s claim set and bibliographic/legal record; those are not provided in the prompt.
- A patent landscape in Japan requires family priority data and legal status, plus competitor identification; none of that is present in the prompt.
- No accurate, claim-specific infringement or FTO conclusions can be produced without the underlying JP7627353 text and record.
FAQs
-
Can you list JP7627353’s claim 1 limitations and dependent claim narrowing?
Not from the information provided.
-
Can you map JP7627353’s scope to likely infringement products (drug substance, salt form, dosing regimen)?
Not without the claim text.
-
Can you determine JP7627353’s patent family and counterpart filings across jurisdictions?
Not from the information provided.
-
Can you identify competing patents and near prior art in Japan that may affect validity or FTO?
Not without the publication’s technical content and bibliographic record.
-
Can you state JP7627353’s legal status in Japan (granted/pending/lapsed, challenges)?
Not from the information provided.
References
[1] None provided in the prompt.
